Abstract. The purpose of this study was to investigate the effect of cyclodextrins (CDs) on aqueous solubility, stability, and in vitro corneal permeability of delta-8-tetrahydrocannabinol (Δ 8 -THC). Phase solubility of Δ 8 -THC was studied in the presence of 2-hydroxypropyl-β-cyclodextrin (HPβCD), randomly methylated-β-cyclodextrin (RMβCD) and sulfobutyl ether-β-cyclodextrin sodium salt (SβCD). Stability of Δ 8 -THC in 5% w/v aqueous CD solutions, as a function of pH, was studied following standard protocols. In vitro corneal permeation of Δ 8 -THC (with and without CDs) across excised rabbit cornea was also determined. Phase-solubility profile of Δ 8 -THC in the presence of both HPβCD and RMβCD was of the A P type, whereas, with SβCD an A L type was apparent. Aqueous solubility of Δ 8 -THC increased to 1.65, 2.4, and 0.64 mg/mL in the presence of 25% w/v HPβCD, RMβCD, and SβCD, respectively. Significant degradation of Δ 8 -THC was not observed within the study period at the pH values studied, except for at pH 1.2. Transcorneal permeation of Δ 8 -THC was dramatically improved in the presence of CDs. The results demonstrate that CDs significantly increase aqueous solubility, stability, and transcorneal permeation of Δ 8 -THC. Thus, topical ophthalmic formulations containing Δ 8 -THC and modified beta CDs may show markedly improved ocular bioavailability.